组蛋白赖氨酸甲基转移酶G9a/GLP是T细胞命运的抑制因子，化学抑制G9a/GLP能够诱导人ipsc来源的CAR-T细胞的成熟和持久性，从而 ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Patients' own stem cells to replace damaged dopamine cells in Parkinson’s disease, offering new hope. Parkinson's disease - ...

Other neurodevelopmental disorders of interest in the lab include autism-spectrum disorders and schizophrenia. We have a long-standing interest in modeling Parkinson’s disease (PD) using human iPSC ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...